Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran

被引:10
|
作者
Mazdak, Hamid [1 ,2 ]
Tolou-Ghamari, Zahra [1 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Kidney Transplantat Res Ctr, Alzahra Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Dept Urol, Esfahan, Iran
关键词
Bladder; Cancer; Incidence; Prevalence; Isfahan;
D O I
10.1016/j.aju.2017.11.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To clarify period prevalence (PP), incidence rate (Ir), and reported mortality for patients with bladder cancer (BC) in Isfahan Province/Iran, as BC is the most common cancer of the urinary tract in Iran and other parts of the world. Patients and methods: Data from 21 March 2011 to 3 March 2015 was obtained from the Isfahan Cancer Registry. BC was distinguished by the related established topography code (C67). Ir and PP were calculated and expressed per 100 000 persons. Results: In all, 279 females and 1376 males were identified. For the total population the PP was calculated as 33.2. This value corresponded to a PP of 54.4 for males and 11.4 for females (P < 0.001). Histologically, 63% of patients had invasive BC. Irs versus mortality rates were calculated for each year, i.e. 2011-2012, 2012-2013, 2013-2014, and 2014-2015, as 7.7 vs 0.56, 8.1 vs 0.74, 7.4 vs 0.98, and 9.9 vs 0.84, respectively. The mean (SD, range) age of the patients was 65.2 (13.9, 3-100) years. In relation to the age of the study population, BC occurred in 12% of patients aged < 50 years and in 15% of those aged >= 80 years. Conclusion: The PP for BC in the male population was 4.8-times higher than females. There was a 28.6% increase in the Ir over the study period. Further study.
引用
下载
收藏
页码:206 / 210
页数:5
相关论文
共 50 条
  • [41] Prevalence of Permanent Congenital Hypothyroidism in Isfahan-Iran
    Hashemipour, Mahin
    Ghasemi, Mahmoud
    Hovsepian, Silva
    Heiydari, Kamal
    Sajadi, Ali
    Hadian, Rezvaneh
    Mansourian, Marjan
    Mirshahzadeh, Naghme
    Dalvi, Marzie
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2013, 4 (12)
  • [42] The Prevalence and Correlates of Hearing Loss in Drivers in Isfahan, Iran
    Janghorbani, Mohsen
    Sheikhi, Ali
    Pourabdian, Siamak
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (02) : 128 - 134
  • [43] Isolation of keratinophilic fungi from soil in Isfahan province, Iran
    Kachuei, R.
    Emami, M.
    Naeimi, B.
    Diba, K.
    JOURNAL DE MYCOLOGIE MEDICALE, 2012, 22 (01): : 8 - 13
  • [44] Prevalence of Hepatitis B Virus Infection in Isfahan Province
    Nokhodian, Zary
    Adibi, Peyman
    Ataei, Behrooz
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2014, 5
  • [45] Molecular identification of Ornithobacterium rhinotracheale in turkeys in Isfahan province of Iran
    Doosti, Abbas
    Sharifzadeh, Ali
    Ghasemi, Hamed
    Vaez, Javad
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (40): : 7911 - 7914
  • [46] The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran
    Mirzaei, Mohammad Reza
    Amini, Massoud
    Aminorroaya, Ashraf
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (07): : 602 - 606
  • [47] STUDY OF AGE OF MENARCHE IN ISFAHAN, IRAN
    SARRAM, M
    MEIBODI, JA
    ZIAI, K
    PAHLAVI MEDICAL JOURNAL, 1974, 5 (03): : 342 - 354
  • [48] Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran
    Rashidian, Hamideh
    Zendehdel, Kazem
    Daroudi, Rajabali
    Ebadzadeh, Mohammad Reza
    Haghdoost, Ali Akbar
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2018, 47 (04) : 567 - 574
  • [49] Epidemiologic and Socioeconomic Status of Bladder Cancer in Mazandaran province, Northern Iran
    Ahmadi, Mohammad
    Ranjbaran, Hossein
    Amiri, Marzeih Momeninejad
    Nozari, Jamshid
    Mirzajani, Mohammad Reza
    Azadbakht, Mohammad
    Hosseinimehr, Seyed Jalal
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5053 - 5056
  • [50] Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran
    Vahedian-Ardakani, Hassan-Ali
    Moghimi, Mansour
    Shayestehpour, Mohammad
    Doosti, Masoud
    Alimohammadi, Fatemeh
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (05)